Journal
BRAIN RESEARCH
Volume 1382, Issue -, Pages 109-117Publisher
ELSEVIER
DOI: 10.1016/j.brainres.2011.01.056
Keywords
Klotho; Vitamin D; Dopamine; Dopaminergic neuron; Parkinson's disease; Neurodegeneration; Aging
Categories
Funding
- Eisai Co., Ltd.
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [18590955]
- Grants-in-Aid for Scientific Research [18590955] Funding Source: KAKEN
Ask authors/readers for more resources
Parkinson's disease (PD), which is characterized by degeneration of mesencephalic dopaminergic neurons of unclear etiology, is primarily an age-related neurodegenerative disorder, while the normal process of aging is also known to decrease the number of dopaminergic neurons in the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA). However, no consensus exists regarding how advancing age may predispose the dopaminergic system to PD. The Klotho-insufficient (klotho) mouse exhibits a syndrome that resembles human aging. Recent studies have revealed that abnormal activation of vitamin D is the major cause of this phenotype. In this study, we examined mesencephalic dopaminergic neurons of klotho mice and identified tyrosine hydroxylase-positive neurons in the SNc and VTA, and found that levels of striatal dopamine were significantly decreased with aging in klotho mice. Notably, these phenotypes were rescued by vitamin D restriction, suggesting that abnormal activation of vitamin D due to Klotho insufficiency leads to degeneration of the dopaminergic system. The present study provides new insights into the pathology of age-related degeneration of dopaminergic neurons possibly related to Klotho-mediated regulation of vitamin D. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available